Fine Line Cir. (517264)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹101.61 |
| Market Cap | ₹48.85 Cr |
| P/E Ratio | 175.13 |
| ROCE | 4.45% |
| ROE | 2.7% |
| Dividend Yield | 0% |
| Profit Growth | 20% |
| Debt/Equity | — |
| Sales Growth | -19.45% |
| 52-Week Range | ₹57.36 — ₹103.66 |
| Sector | IT - Hardware |
| Book Value | ₹18.13 |
Strengths
- Profit growth of 20% while sales fell 19.45% shows some earnings resilience or cost control.
- Piotroski F-Score of 6/9 suggests the company is not in acute financial stress.
- Stock is within ~2% of its 52-week high (₹103.66), indicating market participants see a recovery narrative.
- Annual net profit is positive (P/E 175 implies EPS ~₹0.58), so there is no immediate going-concern red flag.
Concerns
- P/E of 175.13 and P/B of 5.60 are steep for a business earning only 2.70% ROE and 4.45% ROCE.
- Sales contracted -19.45%; the top line is shrinking.
- Latest quarter shows net profit ₹0 Cr on sales ₹8 Cr, so recent earnings power is effectively nil.
- Dividend yield is 0%, so shareholders receive no income while awaiting uncertain recovery.
AI Analysis
When I look at Fine Line Cir., the first thing I ask is what I get for my rupee. At ₹101.61, I'm paying 175 times earnings, 5.6 times book, for a business whose return on equity is 2.70% and return on capital 4.45%. Graham would say that is a very demanding price for a mediocre return. The latest quarter sums up the problem: sales ₹8 crore, net profit ₹0 crore. This is not a franchise with pricing power; it is a small hardware player with no durable moat evident. Sales have shrunk 19.45%, while reported profit rose 20%. I instinctively distrust profit growth that arrives while revenue falls—it may be cost cutting, one-off gains, or less reinvestment in the business. No dividend means I am not being paid to wait. Piotroski F-Score 6/9 is modest, but it cannot offset a P/E of 175. The stock trades near its 52-week high, so the market may be pricing a turnaround. I need evidence, not hope. For me, the margin of safety is missing. A ₹49 crore market cap for a business earning effectively nothing per share in the latest quarter is not an obvious bargain. I would need to see sustained revenue stabilisation, genuine operating profit, and a return on equity moving toward a level that justifies the multiple. Until then, this is a show-me story. I can watch it from the sidelines, but I won't pay a rich price for a poor business.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer